Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

COVID-19 isolation law could end this month in England

February 10, 2022 Business Services

Boris Johnson has said that all remaining COVID-19 restrictions in England – including the legal rule to self-isolate – could …

AI support tool aims to change skin cancer treatment in the NHS

February 10, 2022 Business Services

Chelsea and Westminster Hospital NHS Foundation Trust has announced the expansion of its partnership with Skin Analytics, with the roll …

FDA accepts Dupixent (dupilumab) for children with moderate-to-severe atopic dermatitis

February 10, 2022 Business Services

The FDA has accepted the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for children aged six months to five …

FDA orphan drug designation for treatment of rare blood cancer

February 3, 2022 Business Services

The FDA has granted orphan drug designation (ODD) to tamibarotene for the treatment of myelodysplastic syndrome (MDS). The Office of …

Vaginal HRT tablets to become available over the counter

February 3, 2022 Business Services

Vaginal oestrogen tablets, a type of hormone replacement therapy (HRT) – could become available in chemists soon, depending on the …

Illumina to advance precision medicine approach for late-stage cancer patients

February 3, 2022 Business Services

Illumina announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University in France, to assess the clinical value …

CMA fines firms £35m for illegal arrangement

February 3, 2022 Business Services

The Competition and Markets Authority (CMA) has fined firms over £35 million for an illegal arrangement in the supply of …

Oncology history: Immunocore claims first-ever FDA approval of melanoma drug

January 27, 2022 Business Services

Immunocore has claimed a piece of history in biotech industry, becoming the first company to secure an FDA approval for …

Gilead combo therapy hit with FDA hold over serious adverse events

January 27, 2022 Business Services

The FDA has placed a partial clinical hold on studies conducted by Gilead Sciences assessing the combination of magrolimab plus …
isaac-quesada-sij6sanetye-unsplash

Face mask rules and COVID-19 passes end in England, care home restrictions ease

January 27, 2022 Business Services

The government has announced that there will be no limit on the number of visitors to care homes in England. …

Medidata partners with Circuit Clinical to strengthen clinical trial capabilities

January 27, 2022 Business Services

Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created …

LUMAKRAS (sotorasib) receives approval in Japan for lung cancer patients

January 20, 2022 Business Services

Amgen has announced that LUMAKRAS received approval in Japan for the treatment of patients with KRAS G12C-mutated advanced non-small cell …

All Plan B restrictions to end in England

January 20, 2022 Business Services

Prime Minister Boris Johnson has announced that England’s Plan B measures are to end from 26 January. This will include …

1.27 million deaths a year attributable to antimicrobial resistance

January 20, 2022 Business Services

The Global Research on Antimicrobial Resistance (GRAM) paper has revealed the true scale of antibiotic resistance in Western Europe, and …

Vaccine alliance Gavi says that additional $5.2bn needed to ensure supply

January 20, 2022 Business Services

The chairman of the Gavi vaccine alliance, Jose Manuel Barroso, has said that an additional $5.2 billion is required to …
The Gateway to Local Adoption Series

Latest content